Clinical trials of a low-dose inhibitor of ovulation
Poiret, C.; Picavet, B.
Lille Medical Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 1970(Suppl 4): 737-739
1970
ISSN/ISBN: 0024-3507 PMID: 5428132 Document Number: 24025
Document emailed within 1 workday
Related Documents
Kaiser, E. 1986: Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female Geburtshilfe und Frauenheilkunde 46(10): 738-742Koester, H.; Hertel, H. 1969: Effect and tolerance of a low dose ovulation inhibitor (Orlest) Münchener Medizinische Wochenschrift 111(41): 2103-2109
Benagiano, G.; Bastianelli, C. 1989: Clinical trials of the ovulation method Suppl to International Journal of Gynecology and Obstetrics 1: 91-98
Jain, J.; Dutton, C.; Nicosia, A.; Wajszczuk, C.; Bode, F.R.; Mishell, D.R. 2004: Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera Contraception 70(1): 11-18
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Ryan, G.L.; Moss, V.; Davis, W.A.; Sparks, A.E.T.; Dokras, A.; Van Voorhis, B.J. 2005: Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: cost- and clinical effectiveness Journal of Reproductive Medicine 50(12): 943-950
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Cheson, B.D. 1990: Clinical trials referral resource. High-dose chemo for acute myeloid leukemia Oncology 4(7): 69-70; 72-4; 77-78 Passim
Pratt, C.B.; Roberts, D.; Shanks, E.C.; Warmath, E.L. 1974: Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors Cancer Research 34(12): 3326-3331
Tateishi, T.; Kobayashi, S.; Shigeyama, C.; Nakamura, T.; Kobayashi, H. 1998: Pharmacokinetics of KW-4679 in the elderly: single-dose and multiple-dose trials Drugs under Experimental and Clinical Research 24(1): 1-7
Schneider, W.H.; Schmid, R.; Spona, J. 1981: The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor Wiener Klinische Wochenschrift 93(19): 601-604
Rattanasupar, A.; Sengmanee, S. 2016: Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding Journal of the Medical Association of Thailand 99(9): 988-995
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Weigmann, K. 2015: The ethics of global clinical trials: in developing countries, participation in clinical trials is sometimes the only way to access medical treatment. what should be done to avoid exploitation of disadvantaged populations? Embo Reports 16(5): 566-570